Zenex Animal Health revenue, valuation and funding
Zenex Animal Health reported revenue of ₹1,023 crore in FY25 (the year to March 2025), against ₹823.6 crore in FY24, per filings and statements as reported.
| Revenue (FY25) | ₹1,023 crore |
|---|---|
| Revenue (FY24) | ₹823.6 crore |
| Net profit (FY24) | ₹14.9 crore |
Figures from filings and statements as reported; the table below carries each year with its source.
Zenex Animal Health key facts
- What it doesAnimal health maker Story
- Founded2021
- HeadquartersAhmedabad
- Last round$52.5 million, Growth equity, on 6 December 2021 Story
- StatusPrivate
Zenex Animal Health revenue and profit by year
| Year | Revenue | Profit or loss | Expenses | Note | Source |
|---|---|---|---|---|---|
| FY25 | ₹1,023 crore | latest financials as reported by VCCircle and Inc42 DataLabs; profit left out because the two sources differ slightly (₹26.2 crore and ₹26.4 crore) | VCCircleInc42 DataLabs | ||
| FY24 | ₹823.6 crore | ₹14.9 crore | prior-year figures given by VCCircle | VCCircle |
As reported for each financial year; where sources disagree the figure is left out rather than picked.
Funding rounds
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Dec 2021 | Secondary stake purchase | Up to $52.5 million | IFC (about $16M), Emerging Asia Fund (about $36.5M); sellers: Multiples Private Equity Fund III | VCCircle |
Timeline
- FY25 FY25 results: revenue about ₹1,023 crore, up from ₹823.6 crore VCCircle
- 2021
- May 2021 Multiples-led consortium agrees to buy the animal health business of a Zydus Cadila unit for ₹2,921 crore through Zenex Animal Health India Medical Dialogues
- Dec 2021 IFC and Emerging Asia Fund propose to buy up to $52.5 million of shares from Multiples Private Equity Fund III VCCircle
- 2023
- Dec 2023 Acquires Ayurvet, a herbal animal care company; price not disclosed VCCircle
- 2025
- Dec 2025 Nitendra Patel joins as chief human resources officer Economic Times HRWorld
- 2026
- Feb 2026 Buys a majority stake in Dutch firm VievePharm; price not disclosed Mint
- Apr 2026 Aniruddha Rajurkar named chief executive Indian Pharma Post
- Sep 2026 Buys SAVAVET, the pet care unit of SAVA Healthcare; price not disclosed Moneycontrol
The short version
- Zenex Animal Health makes veterinary medicines and nutrition products for livestock, poultry and pets. MoneycontrolVCCircle
- It began when a consortium led by Multiples Alternate Asset Management, with CPP Investments and RARE Enterprises, agreed in 2021 to buy the animal health business of a Zydus Cadila unit for ₹2,921 crore. Medical Dialogues
- The business had about 700 employees and one factory in Haridwar when the deal was announced. Medical Dialogues
- In December 2021 IFC and its Emerging Asia Fund proposed to buy up to $52.5 million of shares from Multiples Private Equity Fund III. VCCircle
- It bought herbal animal care firm Ayurvet in December 2023, Dutch natural nutrition maker VievePharm (majority stake) in February 2026 and the SAVAVET pet care business of SAVA Healthcare in September 2026; prices were not disclosed. VCCircleMintMoneycontrol
- Aniruddha Rajurkar became chief executive in April 2026, and Nitendra Patel joined as chief human resources officer in December 2025. Indian Pharma PostEconomic Times HRWorld
Deals and partnerships
| When | With | What | Price | Source |
|---|---|---|---|---|
| May 2021 | ZAZydus Animal Health and Investments (India animal health business) | Animal health medicines, with a plant in Haridwar | ₹2,921 crore | Medical Dialogues |
| Dec 2023 | AYAyurvet | Herbal products for livestock, poultry and pets | Undisclosed | VCCircle |
| Feb 2026 | VIVievePharm | Dutch natural animal nutrition products; majority stake | Undisclosed | Mint |
| Sep 2026 | SASAVAVET | Pet care business of SAVA Healthcare | Undisclosed | Moneycontrol |
Products
- Livestock, poultry and pet medicines: Veterinary medicines and nutrition products, with brands added through its acquisitions. VCCircleMoneycontrol
- Natural animal nutrition: Herbal products from Ayurvet and bolus (slow-release tablet) products for minerals, vitamins and udder health from VievePharm. VCCircleMint
People
- Aniruddha Rajurkar: Chief executive since April 2026; earlier chief executive of SAVA Healthcare and Shield Healthcare and head of Dr. Reddy's India business. Indian Pharma Post
- Nitendra Patel: Chief human resources officer since December 2025; earlier chief human resources officer at Symphony. Economic Times HRWorld
Questions people ask about Zenex Animal Health
Who owns Zenex Animal Health?
Zenex is backed by Multiples Alternate Asset Management, whose consortium bought the business in 2021 with CPP Investments and RARE Enterprises. In December 2021 IFC and its Emerging Asia Fund proposed to buy up to $52.5 million of shares from Multiples Private Equity Fund III. Current stakes were not found. Medical DialoguesVCCircle
What does Zenex Animal Health do?
Zenex makes veterinary medicines and nutrition products for livestock, poultry and pets. It started with the animal health business of a Zydus Cadila unit, which had a plant at Haridwar, and has since added Ayurvet, VievePharm and SAVAVET through acquisitions. Medical DialoguesVCCircleMintMoneycontrol
How much did Zenex pay for the Zydus animal health business?
The consortium behind Zenex agreed to pay ₹2,921 crore in a cash-free, debt-free slump sale, reported in May 2021. It was expected to close within 90 days, and a LinkedIn company profile gives July 2021 for the close. The business had about 700 employees. Medical Dialogues
Who is the CEO of Zenex Animal Health?
Aniruddha Rajurkar was named chief executive in April 2026. He earlier ran SAVA Healthcare and Shield Healthcare as chief executive and led Dr. Reddy's India business. Indian Pharma Post
What is Zenex Animal Health's revenue?
Zenex Animal Health reported revenue of about ₹1,023 crore in its latest financials, FY25, up from ₹823.6 crore a year earlier, according to VCCircle and Inc42 DataLabs. Its profit is small, around ₹26 crore, but the two sources differ by a little, so no exact figure is given. No FY26 figure has been reported. VCCircleInc42 DataLabs
Every line links to the article it came from, written in our own words. Not investment advice. Profile updated 2026-11-14.
Stories cover its acquisition, people and funding news. Sectors: Healthcare & Life Sciences. Stages: Growth equity. Based in Ahmedabad. Stories run from 6 December 2021 to 30 September 2026.
Who put in money
Up against
Every story on Zenex Animal Health
- ZA
Zenex Animal Health · Acquisition · 30 September 2026Zenex buys SAVAVET pet care businessZenex makes veterinary medicines for livestock, poultry and pets, and is backed by private equity investor Multiples
- ZA
Zenex Animal Health · People · 10 April 2026Aniruddha Rajurkar named Zenex chief executiveZenex named Aniruddha Rajurkar as chief executive in April 2026 to drive its next growth phase in animal health
- ZA
Zenex Animal Health · Acquisition · 27 February 2026Zenex buys majority stake in VievePharmZenex took a controlling share in VievePharm, a Dutch maker of natural animal nutrition products, for an undisclosed price
- ZA
Zenex Animal Health · People · 15 December 2025Nitendra Patel joins Zenex as HR chiefZenex appointed Nitendra Patel as chief human resources officer in December 2025
- ZA
Zenex Animal Health · Acquisition · 14 December 2023Zenex acquires herbal animal care firm AyurvetZenex bought Ayurvet, a maker of herbal and natural products for livestock, poultry and pets, without disclosing the price
- ZA
Zenex Animal Health · Funding · 6 December 2021 · $52.5 millionIFC and EAF to buy $52.5M Zenex stakeIFC and its Emerging Asia Fund proposed to buy up to $52.5 million of Zenex shares from Multiples Private Equity Fund III
Read next on Zenex Animal Health
For Zenex Animal Health: add the “Featured on StopDown” badge
Put this on your website's press or media page. It links readers to Zenex Animal Health on StopDown.

